Darexaban (YM150) prevents venous thromboembolism in Japanese patients undergoing major abdominal surgery: Phase III randomized, mechanical prophylaxis-controlled, open-label study

Thrombosis Research

Volumn 130, Issue 3, 2012, Pages

  Sakon, Masato ^a   Nakamura, Mashio ^b  

^a Nishinomiya Municipal Central Hospital   (Japan)

^b MIE UNIVERSITY   (Japan)

Author keywords

Abdominal surgery; Factor Xa inhibitor; Japan; Venous thromboembolism

Indexed keywords

DAREXABAN; PLACEBO;

ABDOMINAL ABSCESS; ABDOMINAL DISTENSION; ABDOMINAL SURGERY; ABNORMAL LABORATORY RESULT; ADULT; ARTICLE; BLEEDING; COMPLICATION; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DISUSE SYNDROME; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEPATOBILIARY DISEASE; HUMAN; INCIDENCE; INSOMNIA; JAPANESE; KIDNEY DYSFUNCTION; LIVER FUNCTION TEST; MALE; MECHANICAL PROPHYLAXIS; MULTICENTER STUDY; PARALYTIC ILEUS; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROCEDURAL COMPLICATION; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN DISEASE; SYNDROME; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; VOMITING;

ABDOMEN; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; AZEPINES; BENZAMIDES; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FACTOR XA; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MECHANICAL THROMBOLYSIS; MIDDLE AGED; ORTHOPEDIC PROCEDURES; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 84865230257     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.06.009     Document Type: Article

References (27)

1. A.C. Spyropoulos, M. Hussein, J. Lin, and D. Battleman Rates of symptomatic venous thromboembolism in US surgical patients: a retrospective administrative database study J Thromb Thrombolysis 28 2009 458 464
2. D. Bergqvist, G. Agnelli, A.T. Cohen, A. Eldor, P.E. Nilsson, and A. Le Moigne-Amrani Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer N Engl J Med 346 2002 975 980
3. T. Kobayashi, M. Nakamura, M. Sakuma, N. Yamada, M. Sakon, and S. Fujita Incidence of pulmonary thromboembolism (PTE) and new guidelines for PTE prophylaxis in Japan Clin Hemorheol Microcirc 35 2006 257 259
4. M. Sakon, Y. Maehara, H. Yoshikawa, and H. Akaza Incidence of venous thromboembolism following major abdominal surgery: a multi-center, prospective epidemiological study in Japan J Thromb Haemost 4 2006 581 586
5. S. Fujita, S. Hirota, T. Oda, Y. Kato, Y. Tsukamoto, and T. Fuji Deep venous thrombosis after total hip or total knee arthroplasty in patients in Japan Clin Orthop Relat Res 375 2000 168 174
6. M. Sakon, T. Kobayashi, and T. Shimazui Efficacy and safety of enoxaparin in Japanese patients undergoing curative abdominal or pelvic cancer surgery: results from a multicenter, randomized, open-label study Thromb Res 125 2010 e65 e70
7. S. Schulman, P. Lindmarker, and H. Johnsson Influence of changes in lifestyle on fibrinolytic parameters and recurrence rate in patients with venous thromboembolism Blood Coagul Fibrinolysis 6 1995 311 316
8. E.J. Brommer, J.A. Gevers Leuven, and P. Brakman Lifestyle, fibrinolysis and lipids Pharm World Sci 19 1997 82 88
9. T. Nagakawa, M. Nagamori, F. Futakami, Y. Tsukioka, M. Kayahara, and T. Ohta Results of extensive surgery for pancreatic carcinoma Cancer 77 1996 640 645
10. K. Inokuchi Prolonged survival of stomach cancer patients after extensive surgery and adjuvant treatment: an overview of the Japanese experience Semin Surg Oncol 7 1991 333 338
11. S. Sagae, and R. Kudo Surgery for germ cell tumors Semin Surg Oncol 19 2000 76 81
12. M. Nakamura Japanese Guidelines for prevention of venous thromboembolism J Jpn Soc Clin Anesth 24 2004 480 487
13. JCS Joint Working Group Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2009) Circ J 75 2011 1258 1281
14. M. Sakon, and T. Kobayashi Clinical evaluation of fondaparinux for prevention of venous thromboembolism in Japanese patients undergoing abdominal surgery J Thromb Haemost 7 2009 [Abstract: PP-TH-411]
15. G. Agnelli Current issues in anticoagulation Pathophysiol Haemost Thromb 34 Suppl. 1 2005 2 9
16. A.G. Turpie Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases Arterioscler Thromb Vasc Biol 27 2007 1238 1247
17. A.G. Turpie, K.A. Bauer, B.I. Eriksson, and M.R. Lassen Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies Arch Intern Med 162 2002 1833 1840
18. A.G. Turpie, M.R. Lassen, B.L. Davidson, K.A. Bauer, M. Gent, and L.M. Kwong Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial Lancet 373 2009 1673 1680
19. M.R. Lassen, G.E. Raskob, A. Gallus, G. Pineo, D. Chen, and P. Hornick Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial Lancet 375 2010 807 815
20. B.I. Eriksson, A.G. Turpie, M.R. Lassen, M.H. Prins, G. Agnelli, and P. Kalebo A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery J Thromb Haemost 5 2007 1660 1665
21. B.I. Eriksson, A.G. Turpie, M.R. Lassen, M.H. Prins, G. Agnelli, and P. Kalebo Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX-2) J Thromb Haemost 8 2010 714 721
22. B.I. Eriksson, A.G.G. Turpie, A.S. Gallus, M.R. Lassen, M.H. Prins, and R.W. Renfurm ONYX-3, a double-blind comparison of once- or twice-daily dosing with darexaban (YM150) (30 or 60 mg daily) for preventing venous thromboembolism after elective hip arthroplasty J Thromb Haemost 9 2011 855
23. Editorial Committee on Japanese Guideline for Prevention of Venous Thromboembolism. Japanese Guidelines for Prevention of Venous Thromboembolism 2004 Medical Front International Limited 53 63
24. M.S. Rasmussen, L.N. Jorgensen, P. Wille-Jorgensen, J.D. Nielsen, A. Horn, and A.C. Mohn Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study J Thromb Haemost 4 2006 2384 2390
25. M.J. Leonardi, M.L. McGory, and C.Y. Ko The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: a systematic review of 33 randomized controlled trials Arch Surg 141 2006 790 797 [discussion 7-9]
26. M. Kuroiwa Incidence and characteristics of perioperative pulmonary thromboembolism in Japan J Clin Anesth 30 2006 916 924
27. J.A. Heit, M.D. Silverstein, D.N. Mohr, T.M. Petterson, W.M. O'Fallon, and L.J. Melton III Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study Arch Intern Med 160 2000 809 815